Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cells (2019)
- Authors:
- USP affiliated authors: MORAES, LUIZ ALBERTO BERALDO DE - FFCLRP ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; LOTUFO, LETICIA VERAS COSTA - ICB ; ALMEIDA, LARISSA COSTA DE - ICB ; TEIXEIRA, PAULA REZENDE - ICB ; SANTOS, EVELYNE ALVES DOS - ICB ; BAUERMEISTER, ANELIZE - ICB
- Unidades: FFCLRP; ICB
- DOI: 10.1016/j.bcp.2019.06.016
- Subjects: FARMACOLOGIA; DANO AO DNA; CÓLON; CÉLULAS CULTIVADAS DE TUMOR; ANTINEOPLÁSICOS; NEOPLASIAS DO COLON; ANTIBIÓTICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2019
- Source:
- Título: Biochemical Pharmacology
- ISSN: 1873-2968
- Volume/Número/Paginação/Ano: v. 168, p. 38-47, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ALMEIDA, Larissa Costa de et al. Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cells. Biochemical Pharmacology, v. 168, p. 38-47, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2019.06.016. Acesso em: 04 ago. 2025. -
APA
Almeida, L. C. de, Bauermeister, A., Teixeira, P. R., Santos, E. A. dos, Moraes, L. A. B. de, Machado Neto, J. A., & Costa-Lotufo, L. V. (2019). Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cells. Biochemical Pharmacology, 168, 38-47. doi:10.1016/j.bcp.2019.06.016 -
NLM
Almeida LC de, Bauermeister A, Teixeira PR, Santos EA dos, Moraes LAB de, Machado Neto JA, Costa-Lotufo LV. Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cells [Internet]. Biochemical Pharmacology. 2019 ; 168 38-47.[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.bcp.2019.06.016 -
Vancouver
Almeida LC de, Bauermeister A, Teixeira PR, Santos EA dos, Moraes LAB de, Machado Neto JA, Costa-Lotufo LV. Pradimicin-IRD exhibits antineoplastic effects by inducing DNA damage in colon cancer cells [Internet]. Biochemical Pharmacology. 2019 ; 168 38-47.[citado 2025 ago. 04 ] Available from: https://doi.org/10.1016/j.bcp.2019.06.016 - AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy
- DNA damaging agents and DNA repair: from carcinogenesis to cancer therapy
- Exploring pradimicin-IRD antineoplastic mechanisms and related DNA repair pathways
- What can we learn from commercial insecticides? Efficacy, toxicity, environmental impacts, and future developments
- Enriching cancer pharmacology with drugs of marine origin
- Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño
- ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells
- Compostos híbridos e usos dos referidos compostos
- Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells
- Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas
Informações sobre o DOI: 10.1016/j.bcp.2019.06.016 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
